arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

HEALTHY CHOICE WELLNESS CORP.

HCWC

$0.25 ▲ +0.05 (+23.76%) at close

13 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

HEALTHY CHOICE WELLNESS CORP. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.4M

Dividend Yield —

Revenue Growth -9.9% ↘

Op. Margin -8.9% ↘

ROIC -11.6% ↘

FCF / Share $-0.01

Trailing P/E —

Price / Book 1.3x

FCF Yield —

Debt / Equity 1.32

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$18.25M

↓ -9.9% —

Net Income Profit after all expenses

$-3.68M

↓ -416.2% —

Operating Margin Operating profit as % of sales

-8.9%

↓ -16.2% 22th

FCF / Share Free cash flow per share

$-0.01

↑ +50.6% —

Long-Term Debt Long-term obligations

$6.26M

↓ -14.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	-9.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-349%)	-4.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-220%)	4.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11%)	29.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+638%)	27.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+587%)	24.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+500%)	43.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+987%)	—	—	—	—	—	—
EPS Growth YoY (%)	-142.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	69.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	93.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-190.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-416.2% Weak ↓ Weak Declining Year-over-year change in net income	-201.4% Weak ↓ Weak Declining Year-over-year change in net income	54.0% Excellent ↑ Excellent Improving Year-over-year change in net income	43.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.6% Weak ↑ Weak Improving Year-over-year change in net income	92.6% Excellent Excellent Year-over-year change in net income	-189.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-8.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-159%)	-7.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	-3.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-121%)	-0.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-101%)	-2.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	-1.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-111%)	-2.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-114%)	-3.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-121%)	-3.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-46.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-412%)	-9.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-166%)	—	—
Profit Margin (%) (%)	-20.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-302%)	-8.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-189%)	-6.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-164%)	-1.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-3.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-135%)	-2.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-128%)	-14.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-246%)	-3.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-138%)	-4.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-144%)	-47.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-573%)	-7.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-172%)	—	—
FCF Margin (%) (%)	-1.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-5.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-1.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	4.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-3.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-16.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	0.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.07x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.91x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	3.74x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-5.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-26.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-77.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-410%)	-22.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-20.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-5.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-33.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-23.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-90.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-7.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-83.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-433%)	-6.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	1.32x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+89%)	1.00x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+43%)	1.43x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+104%)	1.69x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+141%)	5.01x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+615%)	4.76x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+581%)	3.95x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+464%)	—	—	0.35x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-51%)	—	—	—
Interest Coverage (x)	-33.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-3.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	-97.01x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$3.92M	$4.28M	$5.46M	$5.03M	$8.85M	$9.28M	$9.79M	—	—	$1.71M	—	—	—
Debt / EBITDA (x)	-5.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.17x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-47.73x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	24.56x Weak ↓ Weak Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	525.98x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	106.42x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-31.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.42x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$0.85	—	$1.39	$1.66	$2.02	—	$1.96	$1.69	$1.72	—	$1.38	—	—
Basic EPS, GAAP (USD)	$-0.17	$-0.05	$-0.09	$-0.03	$-0.07	$-0.05	$-0.29	$-0.06	$-0.08	$-0.82	$-0.10	—	—
Free Cash Flow per Share (USD)	$-0.01	—	$-0.03	$0.08	$0.10	—	—	$-0.05	$-0.28	—	—	—	—
Book Value per Share (USD)	$0.19	$0.37	$0.43	$0.47	$0.20	$0.24	$0.30	$0.98	$0.97	—	$1.64	—	—
Tangible Book Value per Share (USD)	$-0.06	$0.04	$-0.06	$-0.11	$-0.49	$-0.54	$-0.51	$0.98	$0.97	—	$1.64	—	—
Basic Weighted Avg Shares (shares)	21.43M	—	13.72M	12.18M	10.05M	—	9.31M	9.23M	9.23M	—	9.23M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$-4.14M	$-2.73M	$-291.36K	$1.27M	$-2.44M	$-2.23M	$-1.32M	—	—	$-2.63M	—	—	—
LT Debt (USD)	$6.26M	$7.30M	$8.47M	$9.72M	$10.64M	$11.34M	$11.58M	—	—	$3.11M	—	—	—
Total Equity (USD)	$4.74M	$7.31M	$5.91M	$5.76M	$2.13M	$2.38M	$2.93M	$9.00M	$8.98M	$8.99M	$15.13M	$15.49M	$15.51M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$18.25M	$18.71M	$19.04M	$20.20M	$20.26M	$19.65M	$18.23M	$15.59M	$15.89M	$15.85M	$12.70M	—	—
Depreciation Expense (USD)	$380.13K	$407.53K	$432.05K	$434.72K	$429.91K	$428.30K	—	$361.82K	$363.14K	—	—	—	—
Net Income, GAAP (USD)	$-3.68M	$-1.66M	$-1.22M	$-339.36K	$-712.41K	$-550.79K	$-2.66M	$-595.71K	$-701.46K	$-7.49M	$-919.67K	—	—
Operating Cash Flow (USD)	$-199.62K	$-855.08K	$-308.65K	$1.07M	$1.09M	$899.48K	—	$-452.77K	$-2.55M	$49.07K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 13 quarters

HEALTHY CHOICE WELLNESS CORP.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCWC with peers